Dermatofibrosarcoma protuberans in pregnancy: a case series and review of the literature. (5th April 2021)

• Record Type: Journal Article
• Authors: Kibbi, Nour; Wang, David; Wang, Wei‐Lien; Galan, Anjela; Leffell, David J.; Christensen, Sean R.; Panse, Gauri
• Is Part Of: International journal of dermatology. Volume 60:Number 9(2021)
• Page Start: 1114
• Page End: 1119
• Publication Date: 2021-04-05
• Subjects: Dermatology -- Periodicals; 616.5
• DOI: 10.1111/ijd.15497
• Languages: English
• ISSNs: 0011-9059

Abstract

Abstract: Background: Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous sarcoma, which has been reported in pregnancy. This case series reports the clinical and histopathological findings of DFSP in pregnancy. Methods: Eighteen cases of DFSP, including six unreported cases and 12 cases from the literature, were identified. Age, anatomic location, tumor size, changes in tumor characteristics during pregnancy, histopathological features, and treatment were recorded. Follow‐up data, when available, were noted. Results: The average age of the cohort was 30.6 years (range 19–38). Ten tumors (55.6%) were located on the trunk, four (22.2%) on the head and neck, three (16.7%) on the extremities, and one (5.6%) in the genitalia. Most tumors demonstrated features of conventional DFSP (12/18, 66.7%), while the remaining were identified as DFSP with fibrosarcomatous (FS) change (3/18, 16.7%), atrophic DFSP (2/18, 11.1%), and myxoid DFSP (1/18, 5.6%). Treatment was reported in 17 cases, at least nine of which were treated postpartum. Ten patients were treated with excision, while seven underwent Mohs micrographic surgery. Three patients recurred on follow‐up, one with local recurrence and two with distant metastasis. Conclusions: DFSP can undergo enlargement or change in size or color in pregnancy, possibly mediated by hormones. While the majority of cases in this series represented conventional DFSP, unusual clinical and histopathological variants were also present. Treatment in most cases can be safely delayed until after delivery, but recurrent or very large tumors may require treatment prepartum. Close monitoring for recurrence or metastasis is advised.